Search results for "platelet"

showing 10 items of 786 documents


 Donor Exposures in Recipients of Pooled Platelet Concentrates: a Case-Study in Arithmetic, Logic, "Expert Opinion", and the "Peer Review" Proc…

2013

Advocacy for single-donor (rather than pooled) platelets has been based on the absolute increase in the risk of transfusion-transmitted infections (TTIs) from pooled (rather than single-donor) platelets in the population of platelet transfusion recipients. A recent study published in a prestigious medical journal advocated for pooled (rather than single-donor) platelets based on the relative increase in the risk of TTIs from pooled (rather than single-donor) platelets in patients transfused with any blood component. If this policy recommendation for use of pooled (rather than single-donor) platelets were followed in the US, there would be an annual increase in the risk of TTIs by 15-20 reci…

education.field_of_studybusiness.industryBlood componentPopulationGeneral Biochemistry Genetics and Molecular BiologyPeer reviewPlatelet transfusionExpert opinionMedicinePlateletIn patientMedical journalArithmeticbusinesseducationClinical Laboratory
researchProduct

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study

2021

Background: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of HF.Aim: This study aims to investigate sex-specifically the association between PTH concentrations and platelet indices in phenotypes of HF.Methods and Results: PTH and platelet indices (MPV and platelet count) were available in 1,896 participants from the MyoVasc study in Mainz, Germany. Multivariable linear regression models, adjusted for age, sex, season, vitamin D status, cardiovascular risk …

heart failure with preserved ejection fractionBIOMARKERmedicine.medical_specialtyPATHOPHYSIOLOGYheart failureParathyroid hormoneCardiovascular Medicine030204 cardiovascular system & hematologyMPVDISEASE03 medical and health sciences0302 clinical medicineInternal medicineMANAGEMENTVitamin D and neurologymedicineDiseases of the circulatory (Cardiovascular) systemparathyroid hormoneheart failure with reduced ejection fractionPlatelet030212 general & internal medicinePlatelet activationMean platelet volumeVITAMIN-DOriginal ResearchRISKEjection fractionbusiness.industryMORTALITYplatelet countmedicine.diseaseDYSFUNCTIONEndocrinologyRC666-701Heart failureCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessFrontiers in Cardiovascular Medicine
researchProduct

Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies

2018

The complement and coagulation cascades interact at multiple levels in thrombosis and inflammatory diseases. In venous thrombosis, complement factor 3 (C3) is crucial for platelet and tissue factor (TF) procoagulant activation dependent on protein disulfide isomerase (PDI). Furthermore, C5 selectively contributes to the exposure of leukocyte procoagulant phosphatidylserine (PS), which is a prerequisite for rapid activation of monocyte TF and fibrin formation in thrombosis. Here, we show that monoclonal cofactor-independent antiphospholipid antibodies (aPLs) rapidly activate TF on myelomonocytic cells. TF activation is blocked by PDI inhibitor and an anti-TF antibody interfering with PDI bin…

inorganic chemicals0301 basic medicineComplement factor I030204 cardiovascular system & hematologyMonocytesImmunoglobulin GThromboplastinThrombosis and HemostasisMice03 medical and health sciencesTissue factor0302 clinical medicineimmune system diseasesmedicineAnimalsPlateletneoplasmsBlood CoagulationMice KnockoutVenous ThrombosisComplement component 5biologyChemistryMonocyteComplement C5Complement C3Hematologynervous system diseasesbody regions030104 developmental biologymedicine.anatomical_structureCoagulationAntibodies Antiphospholipidbiology.proteinCancer researchAntibodyBlood Advances
researchProduct

Monte Carlo Simulations of Parallel Charged Platelets as an Approach to Tactoid Formation in Clay

2013

The free energy of interaction between parallel charged platelets with divalent counterions has been calculated using Monte Carlo simulations to investigate the electrostatic effects on aggregation. The platelets are primarily intended to represent clay particles. With divalent counterions, the free energy for two platelets or two tactoids (clusters of parallel platelets) shows a minimum at a short separation due to the attraction caused by ion-ion correlations. In a salt-free system, the free energy of interaction has a long-range repulsive tail beyond the minimum. The repulsion increases for tactoids with larger aggregation numbers, whereas the depth of the free-energy minimum is graduall…

inorganic chemicalschemistry.chemical_classificationQuantitative Biology::BiomoleculesMonte Carlo method02 engineering and technologySurfaces and Interfaces010402 general chemistry021001 nanoscience & nanotechnologyCondensed Matter Physics01 natural sciences0104 chemical sciencesDivalentCondensed Matter::Soft Condensed MatterchemistryChemical physicsComputational chemistryElectrochemistryGeneral Materials SciencePlatelet[PHYS.PHYS.PHYS-CHEM-PH]Physics [physics]/Physics [physics]/Chemical Physics [physics.chem-ph]Counterion0210 nano-technologySpectroscopyComputingMilieux_MISCELLANEOUS
researchProduct

State of the art and prospects for halide perovskite nanocrystals

2021

Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG Metal-halide perovskites have rapidly emerged as one of the most promising materials of the 21st century, with many exciting properties and great potential for a broad range of applications, from photovoltaics to optoelectronics and photocatalysis. The ease with which metal-halide perovskites can be synthesized in the form of brightly luminescent colloidal nanocrystals, as well as their tunable and intriguing optical and electronic properties, has attracted researchers from different disciplines of science and technology. In the last few years, there has been a significant progress in the shape-controlled synthesis of …

light-emitting devicesGeneral Physics and AstronomyNanotechnology02 engineering and technology010402 general chemistry01 natural sciences7. Clean energyphotocatalystsmetal-halide perovskite nanocrystalslead-free perovskite nanocrystalsPhotovoltaicsGeneral Materials ScienceNanoscience & NanotechnologyPerovskite (structure)Electronic propertiesPhysicsbusiness.industryPhysicsperovskite nanoplateletsGeneral Engineering021001 nanoscience & nanotechnology0104 chemical sciencesddc:Chemistryphotovoltaicsperovskite nanocubesmetal-halide perovskite nanocrystals; perovskite nanoplatelets; perovskite nanocubes; perovskite nanowires; lead-free perovskite nanocrystals; light-emitting devices; photovoltaics; lasers; photocatalysts; photodetectorsNanocrystalperovskite nanowiresphotodetectors2307 Química Física0210 nano-technologybusinessEngineering sciences. Technologylasers
researchProduct

SPH modeling of blood flow in cerebral aneurysms

Gli aneurismi cerebrali sono dilatazioni patologiche di arterie cerebrali. Queste patologie hanno un intrinseco rischio di rottura con conseguenti emorragie intracraniche. Sebbene i meccanismi di formazione, crescita e rottura degli aneurismi cerebrali non sono ancora del tutto compresi, è comunemente riconosciuto che in questi processi i fattori emodinamici giocano un ruolo molto importante. Le simulazioni numeriche possono fornire utili informazioni sull'emodinamica e possono essere usate per applicazioni cliniche. Nei tradizionali metodi numerici basati su una griglia di calcolo il processo di discretizzazione dei vasi cerebrali sui quali insiste un aneurisma è molto complesso. D’altra p…

mechanical platelet activationSmoothed particle hydrodynamics (SPH)parallel computingHemodynamicsMulti-blockOpen-boundariescerebral aneurysmsPressure Poisson EquationSettore ICAR/01 - Idraulica
researchProduct

Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System

2013

Abstract Introduction Cryopreservation for long term storage of platelets (PLTs) represents a clinical useful method for avoiding platelet shortage. Many studies have tried to define, in vitro and in vivo, the entity and weight of storage-related PLTs lesions with discordant results related to different methods. We have performed an in vitro prospective study to evaluate PLTs count, viability and function of buffy coat derived pooled platelet concentrates (BC-PLTs) treated with dimethyl-sulphoxide (DMSO) and cryopreserved at -80°C with an innovative patented system not requiring laminal flow hoods and external manipulations. Materials and methods Each BC-PLTs was obtained from 5 buffy coats…

medicine.diagnostic_testCryopreserved platelets DMSOImmunologyCell BiologyHematologyBuffy coatBiologyBiochemistryThromboelastographyCryopreservationAndrologyIn vivoHemostasisImmunologymedicinePlateletMean platelet volumeAnnexin A5
researchProduct

Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety

2015

Abstract Background: Cryopreservation of platelets (PLTs) at -80°C with dimethyl sulfoxide (DMSO) can extend their shelf life up to 2 years. Cryopreserved PLTs (CRY-PLTs) are reported to have a greater in vivo hemostatic effect than liquid-stored PLTs. Aims of this study were: i. to evaluate the thrombin generation potential of buffy coat derived cryopreserved PLTs (CRY- BC PLT) in comparison with fresh buffy coat derived platelets concentrates; ii. to determine the efficacy and safety of CRY-PLTs transfusion in hematological patients with severe thrombocytopenia. Materials and methods: BC PLTs were obtained from 5 buffy coats and pooled. The final PLTs concentrates were leukoreduced by fil…

medicine.diagnostic_testP-selectinbusiness.industryImmunologyCell BiologyHematologyBuffy coatBiochemistryThromboelastographyCryopreservationAndrologyTissue factorThrombinIn vivoImmunologymedicinethrombin generation cryopreserved platelets DMSOPlateletbusinessmedicine.drug
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct

Update on Ischemic Heart Disease and Critical Care Cardiology

2014

This article summarizes the main developments reported in 2013 on ischemic heart disease, together with the most important innovations in the management of acute cardiac patients. 3.792 JCR (2014) Q2, 34/123 Cardiac & cardiovascular systems UEM

medicine.medical_specialtyAcute coronary syndromeCritical Caremedicine.medical_treatmentEnfermedad cardiovascularMyocardial InfarctionMyocardial IschemiaDiseaseCardiologíaTratamiento médicoPercutaneous Coronary InterventionSex FactorsSex factorsInternal medicinemedicineHumansMyocardial infarctionAcute Coronary SyndromeIntensive care medicinePatofisiologíaSistema cardiovascularbusiness.industryAge FactorsPercutaneous coronary interventionGeneral Medicinemedicine.diseasePrognosisPrimary PreventionConventional PCICardiologycardiovascular systemPlatelet aggregation inhibitorInfarto de miocardiobusinessIschemic heartPlatelet Aggregation InhibitorsRevista Española de Cardiología (English Edition)
researchProduct